Edward Stanek to Antineoplastic Agents
This is a "connection" page, showing publications Edward Stanek has written about Antineoplastic Agents.
Connection Strength
0.232
-
Calabrese EJ, Staudenmayer JW, Stanek EJ. Drug development and hormesis: changing conceptual understanding of the dose response creates new challenges and opportunities for more effective drugs. Curr Opin Drug Discov Devel. 2006 Jan; 9(1):117-23.
Score: 0.174
-
Calabrese EJ, Staudenmayer JW, Stanek EJ, Hoffmann GR. Hormesis outperforms threshold model in National Cancer Institute antitumor drug screening database. Toxicol Sci. 2006 Dec; 94(2):368-78.
Score: 0.045
-
Calabrese EJ, Stanek EJ, Nascarella MA, Hoffmann GR. Hormesis predicts low-dose responses better than threshold models. Int J Toxicol. 2008 Sep-Oct; 27(5):369-78.
Score: 0.013